Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Jason Gorevic
Health Tech
Teladoc CEO bullish on growth despite rough Q1, falling stock
Teladoc CEO Jason Gorevic is bullish that Teladoc can win in the market in the long run despite current market volatility and growing competition.
Heather Landi
Jun 30, 2022 6:12am
Teladoc stock turbulent on Q4 earnings with modest 2022 guidance
Feb 23, 2022 1:00pm
Teladoc projects $2.03B in 2021 revenue
Jan 10, 2022 10:50am
Teladoc plans to take on risk with virtual primary care
Nov 1, 2021 8:15am
Teladoc stock slides after Q2 losses but revenue jumps 109%
Jul 28, 2021 9:25am
Teladoc CEO bullish on fending off rivals in telehealth space
May 12, 2021 10:08am